Minondas, Stieven Jhon R.

HRN: 10-05-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2023
CEFTRIAXONE 1G (VIAL)
03/06/2023
03/12/2023
IV DRIP
OD
2g
URTI; T/c Tyhphoid Fever
Waiting Final Action 
03/06/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2023
03/12/2023
IV
165mg
Q12
Typhoid
Waiting Final Action 
03/09/2023
MUPIROCIN 2%, 15G (TUBE)
03/09/2023
03/15/2023
TOPICAL
2%
Q8hrs
Soft Tissue Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: